Literature DB >> 33144415

Systemic Review and Meta-analysis of Impact of Splenectomy for Advanced Gastric Cancer.

Chikara Kunisaki1, Sho Sato2, Nobuhiro Tsuchiya2, Jun Watanabe2, Tsutomu Sato2, Kazuhisa Takeda2, Kohei Kasahara3, Takashi Kosaka3, Hirotoshi Akiyama3, Itaru Endo3, Toshihiro Misumi4.   

Abstract

BACKGROUND/AIM: Prophylactic splenectomy has shown no inferiority for tumors not invading the greater curvature side. Despite this, the clinical impact of prophylactic splenectomy for proximal advanced gastric cancer is not clear. This review aimed to clarify the impact of splenectomy for advanced gastric cancer in the upper third of the stomach.
MATERIALS AND METHODS: A systematic review and meta-analysis were conducted based on PubMed and EMBASE databases. The following search terms were used: "gastric cancer" OR "splenectomy" OR upper third of the stomach" OR preservation of the spleen.
RESULTS: Out of 765 articles, 18 studies (combined n=6,341) were included in the analysis. Four randomized controlled trials (RCT) and eight retrospective studies suggested the benefits of spleen-preserving gastrectomy. Six retrospective studies showed no significant benefit of spleen-preserving gastrectomy. Prophylactic splenectomy showed a close association with a higher incidence of postoperative morbidity (pancreatic fistula and anastomotic leakage) with no concomitant improvement in overall survival. Prophylactic splenectomy should not be routinely performed and RCTs are necessary to confirm the impact of splenectomy for cN(+) at the splenic hilum tumors and tumors invading the greater curvature. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Proximal gastric cancer; overall survival; postoperative complication; review; splenectomy

Mesh:

Year:  2020        PMID: 33144415      PMCID: PMC7811676          DOI: 10.21873/invivo.12145

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  37 in total

1.  Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients.

Authors:  Roberto Biffi; Antonio Chiappa; Fabrizio Luca; Simonetta Pozzi; Felice Lo Faso; Sabine Cenciarelli; Bruno Andreoni
Journal:  J Surg Oncol       Date:  2006-04-01       Impact factor: 3.454

2.  Robotic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer.

Authors:  Kun Yang; Minah Cho; Chul Kyu Roh; Won Jun Seo; Seohee Choi; Taeil Son; Hyoung-Il Kim; Woo Jin Hyung
Journal:  Surg Endosc       Date:  2019-04-03       Impact factor: 4.584

3.  Changes in clinicopathological features and survival after gastrectomy for gastric cancer over a 20-year period.

Authors:  H S Ahn; H-J Lee; M-W Yoo; S-H Jeong; D-J Park; H-H Kim; W H Kim; K U Lee; H-K Yang
Journal:  Br J Surg       Date:  2011-02       Impact factor: 6.939

4.  Clinicopathologic characteristics and prognosis of gastric cancer patients underwent gastrectomy combined with splenectomy.

Authors:  Feng Wang; Yue Kang; Hong-liang Zu; Hao Jiang; Lei Zhu; Pei-de Dong; Ying-wei Xue
Journal:  Hepatogastroenterology       Date:  2014 Nov-Dec

5.  The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer.

Authors:  Sung Jin Oh; Woo Jin Hyung; Chen Li; Jyewon Song; Wookho Kang; Sun Young Rha; Hyun Cheol Chung; Seung Ho Choi; Sung Hoon Noh
Journal:  J Surg Oncol       Date:  2009-04-01       Impact factor: 3.454

6.  Clinicopathological features and prognostic impact of splenic hilar lymph node metastasis in proximal gastric carcinoma.

Authors:  Oh Jeong; Mi Ran Jung; Seong Yeob Ryu
Journal:  Eur J Surg Oncol       Date:  2018-10-26       Impact factor: 4.424

7.  AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.

Authors:  Beverley J Shea; Barnaby C Reeves; George Wells; Micere Thuku; Candyce Hamel; Julian Moran; David Moher; Peter Tugwell; Vivian Welch; Elizabeth Kristjansson; David A Henry
Journal:  BMJ       Date:  2017-09-21

8.  Efficacy of prophylactic splenectomy for proximal advanced gastric cancer invading greater curvature.

Authors:  Yu Ohkura; Shusuke Haruta; Junichi Shindoh; Tsuyoshi Tanaka; Masaki Ueno; Harushi Udagawa
Journal:  World J Surg Oncol       Date:  2017-05-25       Impact factor: 2.754

9.  Japanese gastric cancer treatment guidelines 2014 (ver. 4).

Authors: 
Journal:  Gastric Cancer       Date:  2016-06-24       Impact factor: 7.370

10.  Adverse prognostic impact of splenectomy on survival in gastric carcinoma patients: Regression and propensity score matching analysis of 1074 patients.

Authors:  Oh Jeong; Ho Goon Kim; Seong Yeob Ryu; Young Kyu Park; Mi Ran Jung
Journal:  PLoS One       Date:  2018-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.